3-D-QSAR analysis of 2-(oxalylamino) benzoic acid class of protein tyrosine phosphatase 1B inhibitors by CoMFA and Cerius2.GA

被引:24
|
作者
Ramar, Subbiah [1 ]
Bag, Seema [1 ]
Tawari, Nilesh R. [1 ]
Degani, Mariam S. [1 ]
机构
[1] Univ Mumbai, Dept Pharmaceut Sci & Technol, Inst Chem Technol, Bombay 400019, Maharashtra, India
来源
QSAR & COMBINATORIAL SCIENCE | 2007年 / 26卷 / 05期
关键词
antidiabetic activity; Cerius2.GA; comparative molecular field analysis; PTP1B inhibitors; QSAR;
D O I
10.1002/qsar.200630090
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Three-Dimensional Quantitative Structure -Activity Relationship (3-D-QSAR) studies for 2-(oxalylamino) benzoic acids as Protein Tyrosine Phosphatase 1B (PTP1B) inhibitors were performed using the genetic function approximation algorithm (Cerius2.GA) and Comparative Molecular Field Analysis (CoMFA). A five-term equation was developed with crossvalidated r(2) (r(CV)(2)) and conventional correlation coefficient (r(2)) of 0.642 and 0.748, respectively, using Cerius2.GA. The CoMFA model from multifit alignment produced good statistical significance with r(CV)(2) and r(2) of 0.671 and 0.900, respectively. The predictive abilities of Cerius2.GA and CoMFA were determined using a test set of ten molecules giving predictive correlation coefficients of 0.666 and 0.643, respectively, indicating good predictive power. Furthermore, the robustness of the models was verified by bootstrapping analysis. Based on the information derived from Cerius2.GA and CoMFA, we have identified some key features that may be used to design new derivatives and predict their PTP affinities prior to synthesis.
引用
收藏
页码:608 / 617
页数:10
相关论文
共 50 条
  • [31] Design, synthesis and docking studies on phenoxy-3-piperazin-1-yl-propan-2-ol derivatives as protein tyrosine phosphatase 1B inhibitors
    Gupta, Swati
    Pandey, Gyanendra
    Rahuja, Neha
    Srivastava, Arvind K.
    Saxena, Anil K.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (19) : 5732 - 5734
  • [32] 2-Amino- and 2-hydroxymethylbenzimidazolium bromides as protein tyrosine phosphatase 1B (PTP1B) inhibitors and other targets associated with diabetes mellitus
    Spasov, A. A.
    Zhukovskaya, O. N.
    Babkov, D. A.
    Brigadirova, A. A.
    Babkova, V. A.
    Morkovnik, A. S.
    Litvinov, R. A.
    Sokolova, E., V
    RUSSIAN CHEMICAL BULLETIN, 2020, 69 (04) : 774 - 780
  • [33] Rational design and synthesis of novel biphenyl thiazolidinedione conjugates as inhibitors of protein tyrosine phosphatase 1B for the management of type 2 diabetes
    Thareja, Suresh
    Verma, Sant Kumar
    Jain, Akhlesh Kumar
    Kumar, Manoj
    Bhardwaj, Tilak Raj
    JOURNAL OF MOLECULAR STRUCTURE, 2023, 1274
  • [34] Novel protein tyrosine phosphatase 1B inhibitors: interaction requirements for improved intracellular efficacy in type 2 diabetes mellitus and obesity control
    Popov, Doina
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 410 (03) : 377 - 381
  • [35] Design, Synthesis, Biological Activity and Molecular Dynamics Studies of Specific Protein Tyrosine Phosphatase 1B Inhibitors over SHP-2
    Sun, Su-Xia
    Li, Xiao-Bo
    Liu, Wen-Bo
    Ma, Ying
    Wang, Run-Ling
    Cheng, Xian-Chao
    Wang, Shu-Qing
    Liu, Wei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (06): : 12661 - 12674
  • [36] Glycogen synthase kinase-3β regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src
    Yao, Xiu-Qing
    Zhang, Xiao-Xue
    Yin, Yang-Yang
    Liu, Bin
    Luo, Dan-Ju
    Liu, Dan
    Chen, Ning-Ning
    Ni, Zhong-Fei
    Wang, Xiong
    Wang, Qun
    Wang, Jian-Zhi
    Liu, Gong-Ping
    BIOCHEMICAL JOURNAL, 2011, 437 : 335 - 344
  • [37] DESIGN, SYNTHESIS AND BIOLOGICAL ACTIVITY EVALUATION OF 2-MERCAPTO-4(3H)-QUINAZOLINONE DERIVATIVES AS NOVEL INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B
    Li, Hui
    Wang, Jin-Ping
    Yang, Fan
    Liu, Ting
    Qiu, Wen-Wei
    Li, Jing-Ya
    Li, Jia
    Tang, Jie
    HETEROCYCLES, 2012, 85 (08) : 1897 - 1911
  • [38] (2R)-2-(2′,6′-dichioro-4′-dibenzo(b,d)furan-4"-ylphenoxy)-3-phenylpropanoic acid (A-321842) as a protein tyrosine phosphatase 1B (PTP1B) inhibitor with anti-diabetic effects in ob/ob mice
    Pei, ZH
    Zinker, BA
    Gum, RJ
    Jacobsen, PB
    Ballaron, SJ
    Trevillyan, JM
    Nguyen, E
    Marsh, KC
    Liu, G
    Xie, NY
    Jirousek, MR
    DIABETES, 2001, 50 : A401 - A401
  • [39] 7-Phenyl-pyrido[2,3-d]pyrimidine-2,4-diamines: Novel and highly selective protein tyrosine phosphatase 1B inhibitors
    Cheung, Adrian Wai-Hing
    Banner, Bruce
    Bose, Jolly
    Kim, Kyungjin
    Li, Shiming
    Marcopulos, Nicholas
    Orzechowski, Lucja
    Sergi, Joseph A.
    Thakkar, Kshitij C.
    Wang, Bing-Bing
    Yun, Weiya
    Zwingelstein, Catherine
    Berthel, Steven
    Olivier, Andree R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (24) : 7518 - 7522
  • [40] A molecular hybridization approach for the design of selective aldose reductase (ALR2) inhibitors and exploration of their activities against protein tyrosine phosphatase 1B (PTP1B)
    Kousaxidis, Antonios
    Petrou, Anthi
    Rouvim, Philippa
    Bodo, Pavol
    Stefek, Milan
    Nicolaou, Ioannis
    Geronikaki, Athina
    JOURNAL OF MOLECULAR STRUCTURE, 2023, 1271